Lowdose ritonavirboosted darunavir once daily versus ritonavirboosted lopinavir for participants with less than 50 HIV RNA copies per MlWRHI 052 a randomised openlabel phase 3 noninferiority trial

Willem VenterMichelle MoorhouseSimiso SokhelaCelicia SerenataGodspower AkpomiemieAmbar QaviNonkululeko MashabaneNatasha ArulappanJoel Weibo Simet al et alTom BoylesSarah Stacey2023-10-062023-10-06ISI2352-3018https://hdl.handle.net/10539/36419Lowdose ritonavirboosted darunavir once daily versus ritonavirboosted lopinavir for participants with less than 50 HIV RNA copies per MlWRHI 052 a randomised openlabel phase 3 noninferiority trial